Related Experiment Video
Updated: Jan 28, 2026

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
Preeclampsia: Disease biology and burden, its management strategies with reference to India
Ankita Malik1, Babban Jee2, Satish Kumar Gupta1
1Reproductive Cell Biology Lab, National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi 110 067, India.
Insights
Preeclampsia, a pregnancy complication causing hypertension, poses risks for mothers and babies. This review explores its causes, prediction biomarkers, and management strategies, especially in India.
Area of Science:
- Obstetrics and Gynecology
- Cardiovascular Medicine
- Public Health
Background:
- Preeclampsia is a serious pregnancy disorder marked by new-onset hypertension and proteinuria after 20 weeks of gestation.
- It significantly contributes to maternal and fetal mortality and morbidity globally.
- Women with preeclampsia and their offspring face increased long-term risks of cardiovascular and metabolic diseases.
Purpose of the Study:
- To review the pathophysiology and emerging hypotheses on the origin of preeclampsia.
- To identify risk factors associated with preeclampsia development.
- To evaluate potential biomarkers for preeclampsia prediction and discuss its management in India.
Main Methods:
- Literature review of pathophysiology, risk factors, and biomarkers for preeclampsia.
- Analysis of preeclampsia prevalence, healthcare facilities, and management guidelines in India.
- Examination of government policies aimed at combating preeclampsia in the Indian context.
Main Results:
- Preeclampsia incidence is notably higher in developing countries.
- India faces challenges in reducing maternal mortality rates related to preeclampsia.
- The review synthesizes current knowledge on preeclampsia's origins, prediction, and management, with a focus on Indian healthcare.
Conclusions:
- Understanding preeclampsia's complex pathophysiology is crucial for developing effective interventions.
- Biomarker research holds promise for early prediction and improved patient outcomes.
- Tailored management strategies and supportive government policies are essential for addressing preeclampsia in India.
Abstract:
Preeclampsia is the cause of significant maternal and fetal mortality and morbidity. It is characterized by new-onset hypertension and proteinuria after 20 weeks of gestation. Preeclamptic women and children born from preeclamptic pregnancies are at greater risk to develop severe cardiovascular complications and metabolic syndromes later in life. The incidence of preeclampsia is estimated to be seven times higher in developing countries as compared to the developed countries. This review summarizes the pathophysiology of preeclampsia, emerging new hypothesis of its origin, risk factors that make women susceptible to developing preeclampsia and the potential of various biomarkers being studied to predict preeclampsia. The health care of developing countries is continuously challenged by substantial burden of maternal and fetal mortality. India despite being a fast developing country, is still far behind in achieving the required maternal mortality rates as per Millennium Development Goals set by the World Health Organization. Further, this review discusses the prevalence of preeclampsia in India, health facilities to manage preeclampsia, current guidelines and protocols followed and government policies to combat this complication in Indian condition.
Related Concept Videos
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Gastroesophageal Reflux Disease II: Clinical Features and Management
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...

